The Venture Codex Logo

The Venture Codex

India Life Sciences Fund III

Plot No. 1174A, Road No. 56, Jubilee Hills, Hyderabad, Telangana, 500033, India

Overview

InvAscent is the investment advisor to EILSF (Fund I), India Life Sciences Fund II (ILSF-II) and India Life Sciences Fund III (ILSF-III). These funds provide private equity growth capital to companies in the Indian pharmaceutical, healthcare, animal health and medtech industries. Examples of funds usage include capacity expansion, introduction of new products, acquisitions, etc. The typical investment size is in the range of USD 10 - 40 million over the life of the investment for a significant minority stake.

Total investments
2
Lead investments
1
Investments · 12mo
0
Active investors
3

Sector focus

  • Health Care
  • Pharmaceutical
Visit website

Investment portfolio

  • MediBuddy

    Participated · Series C · Feb 2022

    MediBuddy is an Indian digital healthcare platform operating in the healthtech space. The company offers digital healthcare services. It announced it has secured $18 million in funding. The capital came from existing investors Quadria Capital, Lightrock and TEAMFund. The announcement did not disclose the financing instrument, valuation, or operating metrics such as revenue or user counts. No additional future plans or transaction terms were provided in the report. MediBuddy is an end-to-end digital healthcare platform that provides 24x7 access to specialist doctors via video calls, doorstep medicine delivery, at-home lab tests, mental health support and other integrated services. Led by CEO Satish Kannan and based in Bangalore, the platform has catered to the healthcare needs of over 3 crore Indians. The company’s core product integrates telemedicine, diagnostics and pharmacy fulfillment into a single user experience. Following the Series C, MediBuddy plans to invest in customer awareness and hiring. It also intends to strengthen its technology platforms, including data science capabilities, and to fund clinical research and product development. MediBuddy is a digital healthcare platform with a partner network comprising doctors, hospitals, diagnostic centres and pharmacies across India. The company raised Rs 25 crore in a venture debt round led by Stride Ventures. MediBuddy will use the funds to further strengthen its technology, operations and marketing. The financing came as venture debt, not equity. Stride Ventures is a venture debt fund that recently launched its second fund with a target corpus of over Rs 1,000 crore and has disbursed over Rs 200 crore since January. The company operates in the Indian digital healthcare market. MediBuddy is a digital healthcare platform. The company announced it has closed a $40 million Series B funding round. The financing was led by India Life Sciences Fund III, LLC. The round included participation from other, unnamed investors. The announcement was reported in India and provided no additional operational or revenue metrics. No further details on use of proceeds or prior rounds were disclosed in the article. MediBuddy DocsApp, formed by the merger of Bengaluru-based DocsApp and MediBuddy, is a digital healthcare platform providing online specialist doctor consultations, lab tests, preventive health checks and medicine delivery. The joint entity serves over three crore Indians via a partner network of more than 90,000 doctors, 7,000 hospitals, 3,000 diagnostic centres and 2,500 pharmacies, covering over 95% of Indian pin codes. It targets both enterprise and retail customers and aims to deliver an on-demand healthcare platform with strong customer experience. The company plans to use new funding to strengthen its doctor base, patient reach, product, and technology. Leadership said the merger will help establish market leadership and advance the mission of providing high-quality healthcare to a billion people.

Team

  • Hari Buggana

    Founder, Chairman and Managing Director

    LinkedIn
  • Vishy Chebrol

    Co-Founder, Chief Investment Officer and Managing Director

    LinkedIn
  • T.P. Devarajan

    Managing Director

    LinkedIn